Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-16 4:13 pm Sale | 13G | MILLENDO THERAPEUTICS INC MLND | GREAT POINT PARTNERS LLC | 270,000 1.42% | -1,459,759 (-84.39%) | View |
2021-02-16 07:02 am Unchanged | 13G | MILLENDO THERAPEUTICS INC MLND | ROCHE FINANCE LTD | 1,089,180 5.7% | 0 (Unchanged) | View |
2020-07-30 11:12 am Sale | 13D | MILLENDO THERAPEUTICS INC MLND | Bpifrance Participations SA | 590,105 3.1% | -488,565 (-45.29%) | View |
2020-04-08 4:09 pm Sale | 13G | MILLENDO THERAPEUTICS INC MLND | Frazier Healthcare VI L.P. | 621,129 3.4% | -775,486 (-55.53%) | View |
2020-03-17 09:08 am Purchase | 13G | MILLENDO THERAPEUTICS INC MLND | ROCHE FINANCE LTD | 1,089,180 6.2% | 333,333 (+44.10%) | View |
2020-02-14 4:20 pm Purchase | 13G | MILLENDO THERAPEUTICS INC MLND | GREAT POINT PARTNERS LLC | 1,729,759 9.81% | 441,666 (+34.29%) | View |
2019-12-16 2:00 pm Purchase | 13D | OVASCIENCE INC OVAS | Bpifrance Participations SA | 1,078,670 6.1% | 1,078,670 (New Position) | View |